BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

SciClone Pharmaceuticals

About SciClone Pharmaceutical

SciClone is a pharmaceutical company engaged in developing and commercialization of therapeutic drugs to treat life-threatening ilnesses. SciClone’s primary objective is to develop its lead compound ZADAXIN® for the treatment of hepatitis C, hepatitis B and certain cancers.

 

 

 

PRODUCT PIPELINE CHART --PRODUCT DEVELOPMENT

 

ZADAXIN® -- proposed machanism --facilitates the body’s immune response to fight viruses and certain cancers. The compound is a synthetic version of the naturally occurring peptide thymosin alpha 1, generically referred to as thymalfasin. ZADAXIN increases the production of white blood cells, such as T-cells.

SCV-07 -- is a synthetic dipeptide that has demonstrated immunomodulatory activity by increasing T-cell differentiation and function.

 

 

Home Page

Key Statistics for Sciclone

Basic Chart for Sciclone

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com